Literature DB >> 6155165

Lack of correlation between presynaptic inhibition of noradrenaline release and end organ responses during nerve stimulation.

M L Dubocovich, S Z Langer, R Massingham.   

Abstract

1 LD 3098 (cirazoline) is an imidazoline derivative, possessing agonist properties at alpha-adrenoceptor sites.2 When transmitter release was measured directly as tritium overflow from perfused cat spleen preparations, prelabelled with [(3)H]-noradrenaline, LD 3098 was found to be 10 times more selective for presynaptic than for postsynaptic alpha-adrenoceptors.3 In addition, in this preparation, LD 3098 appears to induce a postsynaptic sensitization to the transmitter released by nerve depolarization because under conditions in which [(3)H]-noradrenaline overflow decreased, there was a paradoxical potentiation in the response to nerve stimulation. This potentiation also occurred with a concentration of LD 3098 that did not per se affect stimulation-evoked [(3)H]-noradrenaline release or the basal perfusion pressure of the spleen.4 Both the reduction in (3)H-transmitter release induced through activation of alpha-presynaptic adrenoceptors and the potentiation of the responses to nerve stimulation were concentration-dependent phenomena.5 In pentobarbitone anaesthetized dogs, the heart rate response to low frequency ansa-subclavia stimulation was not affected by LD 3098. Whilst the alpha(1) mediated increase in blood pressure responses to injected noradrenaline and tyramine was significantly potentiated by LD 3098, the beta(1)-mediated heart rate responses to these injected amines were not modified in the presence of LD 3098.6 Thus it is possible that the failure to detect any presynaptic effects with LD 3098 when transmitter release is measured indirectly at the level of the postsynaptic responses is due to end organ sensitivity changes.7 These findings emphasize that caution is necessary when assessing presynaptic alpha-adrenoceptor effects through end organ responses to nerve stimulation both in vitro and in vivo and the need for measurements of transmitter overflow as well as adequate postsynaptic controls in such experiments.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155165      PMCID: PMC2044184          DOI: 10.1111/j.1476-5381.1980.tb10885.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Influence of the frequency of nerve stimulation on the metabolism of 3H-norepinephrine released from the perfused cat spleen: differences observed during and after the period of stimulation.

Authors:  M L Dubocovich; S Z Langer
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

2.  Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery.

Authors:  K Starke; T Endo; H D Taube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  Effects of alpha-adrenoceptor agonists and antagonists on pre- and postsynaptically located alpha-adrenoceptors.

Authors:  G M Drew
Journal:  Eur J Pharmacol       Date:  1976-04       Impact factor: 4.432

Review 4.  Presynaptic regulation of catecholamine release.

Authors:  S Z Langer
Journal:  Biochem Pharmacol       Date:  1974-07-01       Impact factor: 5.858

5.  Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre- and post-synaptic adrenergic receptors.

Authors:  M L Dubocovich; S Z Langer
Journal:  J Physiol       Date:  1974-03       Impact factor: 5.182

6.  Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart.

Authors:  K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system.

Authors:  J R Boissier; J F Giudicelli; J Fichelle; H Schmitt; H Schmitt
Journal:  Eur J Pharmacol       Date:  1968-03       Impact factor: 4.432

8.  Effects of dopamine and alpha-methyl-dopamine on smooth muscle and on the cardiac pacemaker.

Authors:  T H Tsai; S Z Langer; U Trendelenburg
Journal:  J Pharmacol Exp Ther       Date:  1967-05       Impact factor: 4.030

9.  Effects of clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat.

Authors:  J M Armstrong; A L Boura
Journal:  Br J Pharmacol       Date:  1973-04       Impact factor: 8.739

10.  Role of the -adrenoceptor in regulating noradrenaline overflow by nerve stimulation.

Authors:  M A Enero; S Z Langer; R P Rothlin; F J Stefano
Journal:  Br J Pharmacol       Date:  1972-04       Impact factor: 8.739

View more
  4 in total

1.  The beta 1-adrenoceptor antagonist, betaxolol, is not released from the heart of the anaesthetized dog during sympathetic nerve stimulation.

Authors:  N Duval; C R Lee; M T Eon; P Petruzzo; S Z Langer
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

2.  ACTH increases noradrenaline release in the rabbit heart.

Authors:  B Szabo; L Hedler; C Schurr; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

3.  The actions of cirazoline on the rat vas deferens.

Authors:  J R Docherty; J C McGrath
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

4.  The effect of some antidepressants on prejunctional muscarinic receptors on the sympathetic nerves of the isolated rabbit ear artery.

Authors:  Y H Kwok; F Mitchelson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.